|
UBA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70385927589223E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08889564032211E-11 |
| Normal-vs-Stage2 |
1.87750999999237E-05 |
| Normal-vs-Stage3 |
2.78665979180914E-14 |
| Normal-vs-Stage4 |
1.66411329161065E-12 |
| Stage1-vs-Stage2 |
2.930000E-01 |
| Stage1-vs-Stage3 |
1.208490E-02 |
| Stage1-vs-Stage4 |
4.581300E-03 |
| Stage2-vs-Stage3 |
1.021910E-02 |
| Stage2-vs-Stage4 |
2.784700E-03 |
| Stage3-vs-Stage4 |
4.026200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
4.923700E-03 |
| Normal-vs-Asian |
1.15410000445237E-08 |
| Caucasian-vs-AfricanAmerican |
1.638560E-01 |
| Caucasian-vs-Asian |
1.572810E-01 |
| AfricanAmerican-vs-Asian |
5.604600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54352094941623E-13 |
| Normal-vs-Female |
2.11286543816414E-12 |
| Male-vs-Female |
4.148000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.61783952690575E-12 |
| Normal-vs-Age(41-60Yrs) |
1.9604318168831E-12 |
| Normal-vs-Age(61-80Yrs) |
2.39059994022739E-10 |
| Normal-vs-Age(81-100Yrs) |
2.370300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.639600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.199600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.945000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.959400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.028000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.812200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.36349999999108E-05 |
| Classical-VS-Follicular |
6.641900E-03 |
| Classical-VS-Other |
5.587200E-01 |
| Classical-VS-Normal |
1.71263003778677E-12 |
| Tall-VS-Follicular |
5.6264000014572E-08 |
| Tall-VS-Other |
1.418760E-01 |
| Tall-VS-Normal |
1.62947433324234E-12 |
| Follicular-VS-Other |
1.778240E-01 |
| Follicular-VS-Normal |
5.96290000000055E-05 |
| Other-VS-Normal |
2.973400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.98839850035415E-11 |
| Normal-vs-N1 |
6.7079675147852E-13 |
| N0-vs-N1 |
1.705740E-02 |
|
|
